南京聚隆科技股份有限公司相关 债券 2025 年跟踪评级报告 中鹏信评【2025】跟踪第【366】号 01 除因本次评级事项本评级机构与评级对象构成委托关系外，本评级机构及评级从业人员与评级对象不存 在任何足以影响评级行为独立、客观、公正的关联关系。 本评级机构与评级从业人员已履行尽职调查义务，有充分理由保证所出具的评级报告遵循了真实、客观、 公正原则，但不对评级对象及其相关方提供或已正式对外公布信息的合法性、真实性、准确性和完整性 作任何保证。 本评级机构依据内部信用评级标准和工作程序对评级结果作出独立判断，不受任何组织或个人的影响。 本评级报告观点仅为本评级机构对评级对象信用状况的个体意见，不作为购买、出售、持有任何证券的 建议。本评级机构不对任何机构或个人因使用本评级报告及评级结果而导致的任何损失负责。 本次评级结果自本评级报告所注明日期起生效，有效期为被评证券的存续期。同时，本评级机构已对受 评对象的跟踪评级事项做出了明确安排，并有权在被评证券存续期间变更信用评级。本评级机构提醒报 告使用者应及时登陆本公司网站关注被评证券信用评级的变化情况。 本评级报告版权归本评级机构所有，未经授权不得修改、复制、转 ...

Core Insights - The establishment of a "shared factory" in Jiangbei New District focuses on addressing core pain points in industrial upgrading, particularly in the low-altitude aircraft sector [1] - Nanjing Julong Composite Materials Technology Co., Ltd. leads the initiative, having developed over 50 large industrial drones, and aims to create an efficient drone manufacturing ecosystem by consolidating upstream and downstream enterprises [1] - The "shared factory" features a smart manufacturing hub that operates based on real-time order data, enhancing operational efficiency and resource visibility [1] Group 1 - The "shared factory" integrates flexible production lines covering industrial-grade medium to large drones, enabling rapid assembly and testing of drones from raw materials to finished products [2] - The facility includes a 350-meter high-standard runway and various takeoff and landing points, allowing for immediate test flights upon completion [2] - The initiative aims to break down barriers in technology, data, region, and collaboration, creating a new paradigm for drone manufacturing that emphasizes shared space, design, production lines, and testing [2]

Core Viewpoint - The company, Nanjing Julong, is investing 130 million yuan to establish a production project for 40,000 tons of special materials annually, focusing on flame-retardant products to enhance its product structure and market competitiveness [1][2]. Investment and Project Development - The project will utilize approximately 5,800 square meters of space, including 15 production lines and a 2,500-slot storage facility [1]. - The specific materials to be produced have not been disclosed, but they are likely to include modified products of special engineering plastics such as PPA, PEEK, and PPS, expanding the company's offerings beyond modified nylon and polypropylene [2]. Product Focus and Market Demand - The company is concentrating on automotive applications, particularly in battery packs and other critical components, having developed various flame-retardant and high-temperature materials for these uses [3]. - Ongoing projects include a production line for 50,000 tons of special engineering plastics and modified materials, expected to be operational by December 31, 2025 [4]. Emerging Fields and Strategic Direction - The company is also developing materials for emerging fields such as hydrogen storage, robotics, medical health, and communication radar, aligning with its "4 + 2" development strategy focused on high-end equipment, new materials, and aerospace applications [5]. Financial Performance - In 2024, the company achieved a revenue of 2.387 billion yuan, a 30.53% increase year-on-year, marking its first time exceeding 2 billion yuan [6]. - The net profit attributable to shareholders was approximately 84.34 million yuan, reflecting a 16.25% growth compared to the previous year [6]. Sales Breakdown - Sales of modified plastic products for automotive and new energy vehicles reached 1.782 billion yuan, up 31.24% year-on-year [7]. - The aerospace and low-altitude economy sector saw a remarkable revenue increase of 263.80%, generating 30 million yuan [7].

Group 1 - Company GuoDeWei plans to repurchase shares with a total investment of between 100 million to 150 million yuan, with a maximum repurchase price of 53 yuan per share, expecting to buy back between 1.89 million to 2.83 million shares, accounting for 0.78% to 1.17% of total share capital [1] - Company Shuangliang Energy has won a bid for the Gansu Energy Chemical Qinyang 2×660MW coal power project, with a total bid amount of 237 million yuan, representing 1.82% of the company's projected revenue for 2024 [1] - Company China Pacific Insurance reported a total premium income of 227.17 billion yuan from its two subsidiaries in the first five months, with a year-on-year growth of 10.2% for its life insurance subsidiary and 0.5% for its property insurance subsidiary [1][2] Group 2 - Company LuKang Pharmaceutical has received a drug registration certificate for injectable Cefoperazone Sodium, a third-generation cephalosporin with broad-spectrum antibacterial properties [3] - Company 吉祥航空 reported a 4.97% year-on-year increase in passenger turnover in May, with a seat occupancy rate of 86.14%, up 3.70% year-on-year [4][5] - Company DuRui Pharmaceutical's subsidiary has also received a drug registration certificate for injectable Cefoperazone Sodium [6] Group 3 - Company KeLan Software announced that part of the shares held by its controlling shareholder will be auctioned, involving 5.09 million shares, accounting for 1.07% of the total share capital [7] - Company HuaCan Optoelectronics received a government subsidy of 87.84 million yuan, which is expected to positively impact the company's pre-tax profit for 2025 [8] - Company JinZhi Technology has won a bid for projects from the State Grid and China Resources New Energy, with a total bid amount of 84.41 million yuan [9] Group 4 - Company Vision China completed a capital increase for its subsidiary, raising 100 million yuan to accelerate its layout in the AI field [11] - Company Youa Co. received a profit distribution of 96.03 million yuan from its investment in Changsha Bank [13] - Company WanBangde's subsidiary obtained a patent for a deuterated compound, enhancing the chemical stability and reducing toxicity [16] Group 5 - Company DongCheng Pharmaceutical completed the enrollment of all 488 participants in the Phase III clinical trial for Fluorine-18 PSMA peptide injection, aimed at prostate cancer diagnosis [17] - Company China Merchants Expressway announced that its first phase of medium-term notes for 2024 will pay interest on July 2, 2025, with a total issuance of 2.5 billion yuan and an interest rate of 2.35% [18] - Company JinPu Titanium's subsidiary has temporarily suspended production for maintenance due to falling product prices and high production costs [20] Group 6 - Company BeiLu Pharmaceutical received a marketing authorization for Iodinated Contrast Injection in Hungary, marking another approval in the EU [22] - Company LiXing Co. obtained an overseas investment certificate for its wholly-owned subsidiary in Singapore, with a total investment of 2.16 million yuan [24] - Company LangKun Technology won a garbage collection service project with a bid amount of 21.57 million yuan [26] Group 7 - Company KeRui International plans to transfer 55% of its subsidiary Tianjin ZhiRui's equity for 41.96 million yuan [28] - Company Nanjing JuLong intends to invest 130 million yuan to build a production project for special materials with an annual output of 40,000 tons [30] - Company NanShan Intelligent plans to use up to 50 million yuan of idle funds for cash management in safe and liquid financial products [32] Group 8 - Company GuangLian Aviation completed the business change registration for its subsidiary, involving the introduction of strategic investors [34] - Company XiaoFang Pharmaceutical signed a cooperation agreement to develop a new drug for hair loss treatment [36] - Company GuiZhou SanLi plans to sign a 150 million yuan technology transfer and development contract with Guangdong Pharmaceutical University [38] Group 9 - Company ST SiLong's subsidiary received a drug registration certificate for Famotidine injection, used for treating upper gastrointestinal bleeding [52] - Company ZhongKe Information's executive plans to reduce holdings of up to 180,000 shares, accounting for 0.06% of total share capital [53] - Company KeLun Pharmaceutical's injectable Cefoperazone Sodium/Chloride Sodium injection received drug registration approval [54] Group 10 - Company LuXin Investment plans to transfer 10.06% of its stake in LuXin HuiJin for 203 million yuan, aiming to focus on its main business [56] - Company Western Gold plans to acquire 100% of Xinjiang MeiSheng for 1.655 billion yuan [58] - Company JinTou City Development intends to swap assets worth 5.862 billion yuan, changing its main business to urban centralized heating [60]

Group 1 - In May, new RMB deposits exceeded 2 trillion, while new RMB loans were nearly 620 billion, indicating a disparity in growth between deposits and loans due to changes in financial institutions' asset diversification and financing structures [1] - The "Guzi economy" has rapidly exploded, with the Taotian toy industry achieving a market share of 70% during the first phase of the 618 shopping festival, significantly surpassing last year's performance [1] - Micron has confirmed the discontinuation of DDR4 production, with expectations of severe shortages in the coming quarters, particularly affecting the PC and data center sectors [1] Group 2 - The search volume for "LABUBU" on the Xianyu platform surged by 1000% month-over-month, indicating a strong demand for rental services of LABUBU figurines [2] - Multiple counterfeit LABUBU factories in Dongguan have ceased operations, likely due to increased copyright enforcement [2] - Minsheng Securities' chief strategist, Miao Yiling, has left the company, marking a significant change in the firm's research leadership [3] Group 3 - China Pacific Insurance reported a total premium income of 227.169 billion for its two subsidiaries in the first five months, with a year-on-year growth of 10.2% for life insurance [6] - Goldway plans to repurchase shares worth between 100 million to 150 million, with a maximum repurchase price set at 53 yuan per share [11] - Nanjing Julong intends to invest 130 million in a new production project for special materials, aiming for an annual output of 40,000 tons [10] Group 4 - A strategic research collaboration between Stone Pharmaceutical Group and AstraZeneca has been established, with potential earnings exceeding 5 billion from milestone payments and royalties [7] - The China Securities Regulatory Commission has approved the registration application for Jiangxi Aifenda's IPO on the Growth Enterprise Market [6] - Xizi Elevator has appointed Gao Feng as the new chairman following the passing of the previous chairman [4][5]

Group 1 - The company held its sixth supervisory board's ninth meeting on June 12, 2025, with all three supervisors present, and the meeting was conducted in accordance with relevant laws and regulations [1][2] - The supervisory board approved the proposal to sign a project cooperation agreement for an investment project, specifically a special materials production project with an annual capacity of 40,000 tons, with a total investment of 130 million yuan [1][2] - The project is expected to enhance the company's overall development strategy, optimize product structure, and strengthen market competitiveness, with a phased investment plan that will not adversely affect the company's financial and operational status [1][2]

Group 1 - The company, Nanjing Julong, plans to invest 130 million yuan to establish a production project for special materials with an annual output of 40,000 tons [1] - The project will involve the construction of a new production line and a three-dimensional warehouse, primarily focusing on the production of flame-retardant products [1] - The investment progress of the project will be phased and implemented based on market development conditions [1]

| 证券代码：300644 | 证券简称：南京聚隆 | 公告编号：2025-060 | | --- | --- | --- | | 债券代码：123209 | 债券简称：聚隆转债 | | 南京聚隆科技股份有限公司 第六届监事会第九次会议决议公告 一、监事会会议召开情况 南京聚隆科技股份有限公司（以下简称"公司"）第六届监事会第九次会 议于 2025 年 6 月 12 日在公司会议室现场召开。会议通知已于 2025 年 6 月 5 日 以邮件、专人送达方式发出。公司应参会监事 3 名，实际参加会议监事 3 名， 会议由监事会主席徐俊海先生主持，公司董事会秘书、证券事务代表列席了会 议。本次会议的召集、召开和表决程序符合《公司法》等有关法律法规和《公 司章程》的规定，形成的决议合法有效。 二、监事会会议审议情况 经与会监事认真审议，会议以记名投票表决方式通过了以下议案： 公司监事会在审阅《项目合作协议》等相关资料后，认为公司拟投资 1.3 亿元建设的"聚隆科技年产 4 万吨特种材料生产项目"，有助于持续推进公司 的总体发展战略，进一步优化公司产品结构，增强市场竞争力。项目投资进度 视市场发展情势，分期投资及实施， ...

| 证券代码：300644 | 证券简称：南京聚隆 | 公告编号：2025-061 | | --- | --- | --- | | 债券代码：123209 | 债券简称：聚隆转债 | | 南京聚隆科技股份有限公司 关于公司签署《项目合作协议》暨投资建设项目的公告 本公司及董事会全体成员保证信息披露的内容真实、准确和完整，没有虚 假记载、误导性陈述或重大遗漏。 南京聚隆科技股份有限公司（以下简称"公司"）于 2025 年 6 月 12 日召 开第六届董事会第十二次会议和第六届监事会第九次会议，审议通过了《关于 公司签署〈项目合作协议〉暨投资建设项目的议案》，现将有关内容公告如下： （一）签约主体：本公司和南京江北新区智能制造产业发展管理办公室 一、投资项目概述 为推进公司发展战略，扩大规模，满足市场需求，降本增效，提升智能化 制造水平，公司拟与南京江北新区智能制造产业发展管理办公室签订《项目合 作协议》。公司将在南京江北新区新锦湖路 6 号租赁 5800 ㎡厂房，项目总投资 1.3 亿元，投资建设"聚隆科技年产 4 万吨特种材料生产项目"。该项目将新建 特种材料生产线及立体库，主要生产阻燃类产品，旨在进一步优化 ...

| 证券代码：300644 | 证券简称：南京聚隆 | 公告编号：2025-059 | | --- | --- | --- | | 债券代码：123209 | 债券简称：聚隆转债 | | 公司董事会战略委员会已审议通过了该议案，并同意提交董事会审议。 具 体 内 容 详 见 公 司 于 2025 年 6 月 13 日 在 巨 潮 资 讯 网 （www.cninfo.com.cn）披露的《关于公司签署〈项目合作协议〉暨投资建设 项目的公告》。 南京聚隆科技股份有限公司 第六届董事会第十二次会议决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确和完整，没有虚 假记载、误导性陈述或重大遗漏。 一、董事会会议召开情况 南京聚隆科技股份有限公司（以下简称"公司"）第六届董事会第十二次 会议（以下简称"会议"）于 2025 年 6 月 12 日以通讯表决方式召开。会议通 知已于 2025 年 6 月 5 日以邮件、专人送达方式发出。公司应参会董事 7 名，实 际参加会议董事 7 名。本次会议由董事长刘曙阳先生主持，公司全体监事和高 级管理人员列席了会议，会议的召集和召开符合《公司法》和《公司章程》等 有关规定， ...